Slideshow

Antibody Testing in Patients With Neurological and Psychiatric Symptoms

New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Related Videos
Satyanarayana Gedela, MD
Satyanarayana Gedela, MD
© 2025 MJH Life Sciences

All rights reserved.